The use of soluble VCAM-1 over membrane-bound VCAM-1 could be a limitation because it is the membrane-bound VCAM-1 that binds directly to leukocytes in the progression of atherosclerosis (18). The gene discussed is VCAM1; the disease is atherosclerosis.